{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T17:17:32Z","timestamp":1794331052908,"version":"4.9.0"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2012,12,1]],"date-time":"2012-12-01T00:00:00Z","timestamp":1354320000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"published-print":{"date-parts":[[2012,12]]},"DOI":"10.1186\/1471-2407-12-615","type":"journal-article","created":{"date-parts":[[2012,12,22]],"date-time":"2012-12-22T06:14:38Z","timestamp":1356156878000},"source":"Crossref","is-referenced-by-count":91,"title":["Re-directed T cells for the treatment of fibroblast activation protein (FAP)-positive malignant pleural mesothelioma (FAPME-1)"],"prefix":"10.1186","volume":"12","author":[{"given":"Ulf","family":"Petrausch","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petra C","family":"Schuberth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Hagedorn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alex","family":"Soltermann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra","family":"Tomaszek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rolf","family":"Stahel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Walter","family":"Weder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoph","family":"Renner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,12,22]]},"reference":[{"issue":"15","key":"3705_CR1","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.1056\/NEJMra050152","volume":"353","author":"BW Robinson","year":"2005","unstructured":"Robinson BW, Lake RA: Advances in malignant mesothelioma. N Engl J Med. 2005, 353 (15): 1591-1603. 10.1056\/NEJMra050152.","journal-title":"N Engl J Med"},{"issue":"3","key":"3705_CR2","doi-asserted-by":"publisher","first-page":"379","DOI":"10.2486\/indhealth.45.379","volume":"45","author":"C Bianchi","year":"2007","unstructured":"Bianchi C, Bianchi T: Malignant mesothelioma: global incidence and relationship with asbestos. Ind Health. 2007, 45 (3): 379-387. 10.2486\/indhealth.45.379.","journal-title":"Ind Health"},{"issue":"3","key":"3705_CR3","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1038\/ncponc1039","volume":"5","author":"DA Fennell","year":"2008","unstructured":"Fennell DA, Gaudino G, O'Byrne KJ, Mutti L, van Meerbeeck J: Advances in the systemic therapy of malignant pleural mesothelioma. Nat Clin Pract Oncol. 2008, 5 (3): 136-147.","journal-title":"Nat Clin Pract Oncol"},{"issue":"4","key":"3705_CR4","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1016\/j.ejcts.2006.01.015","volume":"29","author":"I Opitz","year":"2006","unstructured":"Opitz I, Kestenholz P, Lardinois D, Muller M, Rousson V, Schneiter D, Stahel R, Weder W: Incidence and management of complications after neoadjuvant chemotherapy followed by extrapleural pneumonectomy for malignant pleural mesothelioma. Eur J Cardiothorac Surg. 2006, 29 (4): 579-584. 10.1016\/j.ejcts.2006.01.015.","journal-title":"Eur J Cardiothorac Surg"},{"issue":"2","key":"3705_CR5","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1053\/j.semtcvs.2009.07.004","volume":"21","author":"W Weder","year":"2009","unstructured":"Weder W, Opitz I, Stahel R: Multimodality strategies in malignant pleural mesothelioma. Semin Thorac Cardiovasc Surg. 2009, 21 (2): 172-176. 10.1053\/j.semtcvs.2009.07.004.","journal-title":"Semin Thorac Cardiovasc Surg"},{"issue":"3","key":"3705_CR6","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1097\/00000658-199609000-00005","volume":"224","author":"DJ Sugarbaker","year":"1996","unstructured":"Sugarbaker DJ, Garcia JP, Richards WG, Harpole DH, Healy-Baldini E, DeCamp MM, Mentzer SJ, Liptay MJ, Strauss GM, Swanson SJ: Extrapleural pneumonectomy in the multimodality therapy of malignant pleural mesothelioma. Results in 120 consecutive patients. Ann Surg. 1996, 224 (3): 288-294. 10.1097\/00000658-199609000-00005. discussion 294\u2013286","journal-title":"Ann Surg"},{"issue":"5","key":"3705_CR7","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1510\/icvts.2010.256271","volume":"12","author":"I Zahid","year":"2011","unstructured":"Zahid I, Sharif S, Routledge T, Scarci M: Is pleurectomy and decortication superior to palliative care in the treatment of malignant pleural mesothelioma?. Interact Cardiovasc Thorac Surg. 2011, 12 (5): 812-817. 10.1510\/icvts.2010.256271.","journal-title":"Interact Cardiovasc Thorac Surg"},{"issue":"3","key":"3705_CR8","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1016\/j.ejcts.2009.08.016","volume":"37","author":"T Treasure","year":"2010","unstructured":"Treasure T: Surgery for mesothelioma: MARS landing and future missions. Eur J Cardiothorac Surg. 2010, 37 (3): 509-510. 10.1016\/j.ejcts.2009.08.016.","journal-title":"Eur J Cardiothorac Surg"},{"issue":"13","key":"3705_CR9","doi-asserted-by":"publisher","first-page":"2304","DOI":"10.1016\/j.ejca.2009.04.028","volume":"45","author":"J Francart","year":"2009","unstructured":"Francart J, Vaes E, Henrard S, Legrand C, Baas P, Gaafar R, van Meerbeeck JP, Sylvester R, Robert A: A prognostic index for progression-free survival in malignant mesothelioma with application to the design of phase II trials: a combined analysis of 10 EORTC trials. Eur J Cancer. 2009, 45 (13): 2304-2311. 10.1016\/j.ejca.2009.04.028.","journal-title":"Eur J Cancer"},{"issue":"6","key":"3705_CR10","doi-asserted-by":"publisher","first-page":"1466","DOI":"10.1172\/JCI32446","volume":"117","author":"CH June","year":"2007","unstructured":"June CH: Adoptive T cell therapy for cancer in the clinic. J Clin Invest. 2007, 117 (6): 1466-1476. 10.1172\/JCI32446.","journal-title":"J Clin Invest"},{"issue":"1","key":"3705_CR11","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/s002620000169","volume":"50","author":"N Renkvist","year":"2001","unstructured":"Renkvist N, Castelli C, Robbins PF, Parmiani G: A listing of human tumor antigens recognized by T cells. Canc Immunol Immunother. 2001, 50 (1): 3-15. 10.1007\/s002620000169.","journal-title":"Canc Immunol Immunother"},{"issue":"3","key":"3705_CR12","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1007\/s00262-004-0560-6","volume":"54","author":"L Novellino","year":"2005","unstructured":"Novellino L, Castelli C, Parmiani G: A listing of human tumor antigens recognized by T cells: March 2004 update. Canc Immunol Immunother. 2005, 54 (3): 187-207. 10.1007\/s00262-004-0560-6.","journal-title":"Canc Immunol Immunother"},{"issue":"17","key":"3705_CR13","doi-asserted-by":"publisher","first-page":"2713","DOI":"10.1016\/j.yexcr.2010.04.032","volume":"316","author":"K Rasanen","year":"2010","unstructured":"Rasanen K, Vaheri A: Activation of fibroblasts in cancer stroma. Exp Cell Res. 2010, 316 (17): 2713-2722. 10.1016\/j.yexcr.2010.04.032.","journal-title":"Exp Cell Res"},{"issue":"51","key":"3705_CR14","doi-asserted-by":"publisher","first-page":"36505","DOI":"10.1074\/jbc.274.51.36505","volume":"274","author":"JE Park","year":"1999","unstructured":"Park JE, Lenter MC, Zimmermann RN, Garin-Chesa P, Old LJ, Rettig WJ: Fibroblast activation protein, a dual specificity serine protease expressed in reactive human tumor stromal fibroblasts. J Biol Chem. 1999, 274 (51): 36505-36512. 10.1074\/jbc.274.51.36505.","journal-title":"J Biol Chem"},{"issue":"12","key":"3705_CR15","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1038\/nri2669","volume":"9","author":"L Klein","year":"2009","unstructured":"Klein L, Hinterberger M, Wirnsberger G, Kyewski B: Antigen presentation in the thymus for positive selection and central tolerance induction. Nat Rev Immunol. 2009, 9 (12): 833-844. 10.1038\/nri2669.","journal-title":"Nat Rev Immunol"},{"issue":"8","key":"3705_CR16","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1056\/NEJMoa1103849","volume":"365","author":"DL Porter","year":"2011","unstructured":"Porter DL, Levine BL, Kalos M, Bagg A, June CH: Chimeric Antigen Receptor-Modified T Cells in Chronic Lymphoid Leukemia. N Engl J Med. 2011, 365 (8): 725-733. 10.1056\/NEJMoa1103849.","journal-title":"N Engl J Med"},{"issue":"12","key":"3705_CR17","doi-asserted-by":"publisher","first-page":"1774","DOI":"10.1172\/JCI200422284","volume":"114","author":"JH Pinthus","year":"2004","unstructured":"Pinthus JH, Waks T, Malina V, Kaufman-Francis K, Harmelin A, Aizenberg I, Kanety H, Ramon J, Eshhar Z: Adoptive immunotherapy of prostate cancer bone lesions using redirected effector lymphocytes. J Clin Invest. 2004, 114 (12): 1774-1781.","journal-title":"J Clin Invest"},{"issue":"14","key":"3705_CR18","doi-asserted-by":"publisher","first-page":"5784","DOI":"10.1073\/pnas.0901425106","volume":"106","author":"G Stewart-Jones","year":"2009","unstructured":"Stewart-Jones G, Wadle A, Hombach A, Shenderov E, Held G, Fischer E, Kleber S, Nuber N, Stenner-Liewen F, Bauer S, et al: Rational development of high-affinity T-cell receptor-like antibodies. Proc Natl Acad Sci USA. 2009, 106 (14): 5784-5788. 10.1073\/pnas.0901425106.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"13","key":"3705_CR19","doi-asserted-by":"publisher","first-page":"e20","DOI":"10.1200\/JCO.2006.05.9964","volume":"24","author":"CH Lamers","year":"2006","unstructured":"Lamers CH, Sleijfer S, Vulto AG, Kruit WH, Kliffen M, Debets R, Gratama JW, Stoter G, Oosterwijk E: Treatment of metastatic renal cell carcinoma with autologous T-lymphocytes genetically retargeted against carbonic anhydrase IX: first clinical experience. J Clin Oncol. 2006, 24 (13): e20-e22. 10.1200\/JCO.2006.05.9964.","journal-title":"J Clin Oncol"},{"issue":"6","key":"3705_CR20","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1080\/14653240601056396","volume":"8","author":"CH Lamers","year":"2006","unstructured":"Lamers CH, van Elzakker P, Langeveld SC, Sleijfer S, Gratama JW: Process validation and clinical evaluation of a protocol to generate gene-modified T lymphocytes for imunogene therapy for metastatic renal cell carcinoma: GMP-controlled transduction and expansion of patient's T lymphocytes using a carboxy anhydrase IX-specific scFv transgene. Cytotherapy. 2006, 8 (6): 542-553. 10.1080\/14653240601056396.","journal-title":"Cytotherapy"},{"issue":"1","key":"3705_CR21","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1182\/blood-2010-07-294520","volume":"117","author":"CH Lamers","year":"2011","unstructured":"Lamers CH, Willemsen R, van Elzakker P, van Steenbergen-Langeveld S, Broertjes M, Oosterwijk-Wakka J, Oosterwijk E, Sleijfer S, Debets R, Gratama JW: Immune responses to transgene and retroviral vector in patients treated with ex vivo-engineered T cells. Blood. 2011, 117 (1): 72-82. 10.1182\/blood-2010-07-294520.","journal-title":"Blood"},{"issue":"6","key":"3705_CR22","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1200\/JCO.1994.12.6.1193","volume":"12","author":"S Welt","year":"1994","unstructured":"Welt S, Divgi CR, Scott AM, Garin-Chesa P, Finn RD, Graham M, Carswell EA, Cohen A, Larson SM, Old LJ, et al: Antibody targeting in metastatic colon cancer: a phase I study of monoclonal antibody F19 against a cell-surface protein of reactive tumor stromal fibroblasts. J Clin Oncol. 1994, 12 (6): 1193-1203.","journal-title":"J Clin Oncol"},{"issue":"5","key":"3705_CR23","first-page":"1639","volume":"9","author":"AM Scott","year":"2003","unstructured":"Scott AM, Wiseman G, Welt S, Adjei A, Lee FT, Hopkins W, Divgi CR, Hanson LH, Mitchell P, Gansen DN, et al: A Phase I dose-escalation study of sibrotuzumab in patients with advanced or metastatic fibroblast activation protein-positive cancer. Clin Cancer Res. 2003, 9 (5): 1639-1647.","journal-title":"Clin Cancer Res"},{"issue":"1","key":"3705_CR24","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1159\/000069863","volume":"26","author":"RD Hofheinz","year":"2003","unstructured":"Hofheinz RD, al-Batran SE, Hartmann F, Hartung G, Jager D, Renner C, Tanswell P, Kunz U, Amelsberg A, Kuthan H, et al: Stromal antigen targeting by a humanised monoclonal antibody: an early phase II trial of sibrotuzumab in patients with metastatic colorectal cancer. Onkologie. 2003, 26 (1): 44-48. 10.1159\/000069863.","journal-title":"Onkologie"},{"issue":"9","key":"3705_CR25","doi-asserted-by":"publisher","first-page":"3175","DOI":"10.1158\/0008-5472.CAN-10-4035","volume":"71","author":"HC Ertl","year":"2011","unstructured":"Ertl HC, Zaia J, Rosenberg SA, June CH, Dotti G, Kahn J, Cooper LJ, Corrigan-Curay J, Strome SE: Considerations for the clinical application of chimeric antigen receptor T cells: observations from a recombinant DNA Advisory Committee Symposium held June 15, 2010. Cancer Res. 2011, 71 (9): 3175-3181. 10.1158\/0008-5472.CAN-10-4035.","journal-title":"Cancer Res"},{"issue":"6","key":"3705_CR26","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1002\/jgm.2604","volume":"14","author":"KJ Curran","year":"2012","unstructured":"Curran KJ, Pegram HJ, Brentjens RJ: Chimeric antigen receptors for T cell immunotherapy: current understanding and future directions. J Gene Med. 2012, 14 (6): 405-415. 10.1002\/jgm.2604.","journal-title":"J Gene Med"},{"issue":"4","key":"3705_CR27","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1038\/nri3191","volume":"12","author":"NP Restifo","year":"2012","unstructured":"Restifo NP, Dudley ME, Rosenberg SA: Adoptive immunotherapy for cancer: harnessing the T cell response. Nat Rev Immunol. 2012, 12 (4): 269-281. 10.1038\/nri3191.","journal-title":"Nat Rev Immunol"},{"issue":"6","key":"3705_CR28","doi-asserted-by":"publisher","first-page":"R171","DOI":"10.1186\/ar2080","volume":"8","author":"S Bauer","year":"2006","unstructured":"Bauer S, Jendro MC, Wadle A, Kleber S, Stenner F, Dinser R, Reich A, Faccin E, Godde S, Dinges H, et al: Fibroblast activation protein is expressed by rheumatoid myofibroblast-like synoviocytes. Arthritis Res Ther. 2006, 8 (6): R171-10.1186\/ar2080.","journal-title":"Arthritis Res Ther"},{"issue":"5","key":"3705_CR29","doi-asserted-by":"publisher","first-page":"1224","DOI":"10.1002\/art.27395","volume":"62","author":"C Ospelt","year":"2010","unstructured":"Ospelt C, Mertens JC, Jungel A, Brentano F, Maciejewska-Rodriguez H, Huber LC, Hemmatazad H, Wuest T, Knuth A, Gay RE, et al: Inhibition of fibroblast activation protein and dipeptidylpeptidase 4 increases cartilage invasion by rheumatoid arthritis synovial fibroblasts. Arthritis Rheum. 2010, 62 (5): 1224-1235. 10.1002\/art.27395.","journal-title":"Arthritis Rheum"},{"issue":"21","key":"3705_CR30","doi-asserted-by":"publisher","first-page":"2713","DOI":"10.1093\/eurheartj\/ehq519","volume":"32","author":"CE Brokopp","year":"2011","unstructured":"Brokopp CE, Schoenauer R, Richards P, Bauer S, Lohmann C, Emmert MY, Weber B, Winnik S, Aikawa E, Graves K, et al: Fibroblast activation protein is induced by inflammation and degrades type I collagen in thin-cap fibroatheromata. Eur Heart J. 2011, 32 (21): 2713-2722. 10.1093\/eurheartj\/ehq519.","journal-title":"Eur Heart J"},{"issue":"4","key":"3705_CR31","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1038\/mt.2010.24","volume":"18","author":"RA Morgan","year":"2010","unstructured":"Morgan RA, Yang JC, Kitano M, Dudley ME, Laurencot CM, Rosenberg SA: Case report of a serious adverse event following the administration of T cells transduced with a chimeric antigen receptor recognizing ERBB2. Mol Ther. 2010, 18 (4): 843-851. 10.1038\/mt.2010.24.","journal-title":"Mol Ther"},{"issue":"4","key":"3705_CR32","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1007\/s10875-011-9532-8","volume":"31","author":"AC Parente-Pereira","year":"2011","unstructured":"Parente-Pereira AC, Burnet J, Ellison D, Foster J, Davies DM, van der Stegen S, Burbridge S, Chiapero-Stanke L, Wilkie S, Mather S, et al: Trafficking of CAR-engineered human T cells following regional or systemic adoptive transfer in SCID beige mice. J Clin Immunol. 2011, 31 (4): 710-718. 10.1007\/s10875-011-9532-8.","journal-title":"J Clin Immunol"},{"issue":"12","key":"3705_CR33","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1038\/ncponc0666","volume":"3","author":"P Muranski","year":"2006","unstructured":"Muranski P, Boni A, Wrzesinski C, Citrin DE, Rosenberg SA, Childs R, Restifo NP: Increased intensity lymphodepletion and adoptive immunotherapy\u2013how far can we go?. Nat Clin Pract Oncol. 2006, 3 (12): 668-681.","journal-title":"Nat Clin Pract Oncol"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2407-12-615.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-2407-12-615\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2407-12-615","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,21]],"date-time":"2017-06-21T00:45:53Z","timestamp":1498005953000},"score":1,"resource":{"primary":{"URL":"http:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/1471-2407-12-615"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,12]]},"references-count":33,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,12]]}},"alternative-id":["3705"],"URL":"https:\/\/doi.org\/10.1186\/1471-2407-12-615","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,12]]},"article-number":"615"}}